1. Home
  2. GOSS vs SMTI Comparison

GOSS vs SMTI Comparison

Compare GOSS & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.17

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$22.02

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
SMTI
Founded
2015
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7M
208.2M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
GOSS
SMTI
Price
$0.17
$22.02
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$4.19
$34.00
AVG Volume (30 Days)
15.7M
45.5K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$48,471,000.00
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
$201.64
$12.48
P/E Ratio
N/A
$440.40
Revenue Growth
N/A
32.47
52 Week Low
$0.14
$16.05
52 Week High
$3.87
$35.70

Technical Indicators

Market Signals
Indicator
GOSS
SMTI
Relative Strength Index (RSI) 33.36 51.85
Support Level $0.16 $20.52
Resistance Level $0.36 $24.17
Average True Range (ATR) 0.02 1.42
MACD 0.01 -0.17
Stochastic Oscillator 29.41 47.99

Price Performance

Historical Comparison
GOSS
SMTI

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: